Search research articles
Contact Us
Filters
Showing results (61-70 of 85) with videos related to
Page
of 9
Sort By:
Cleveland Clinic Journal of Medicine
|
September 2, 2025
Optimizing hypertension treatment: Evidence-based approaches and new drugs
Astefanos Al-Dalakta, Ahmad Ghanem, Chadi Tabaja, et al.
American Journal of Preventive Cardiology
|
July 6, 2026
The impact of bempedoic acid on cardiovascular events across the spectrum of kidney function, a CLEAR Outcomes trial secondary analysis
Carolina P Zingano, Danielle Brennan, LeAnne Bloedon, et al.
Current Cardiology Reports
|
August 14, 2024
Blood Pressure Time in Target Range and its Impact on Clinical Outcomes
Astefanos Al-Dalakta, Chadi Tabaja, Issam Motairek, et al.
Clinical Kidney Journal
|
August 5, 2025
From pathophysiology to novel approaches for obesity-associated hypertension
Mehmet Kanbay, Elif Yayci, Candan Genc, et al.
Journal of Cardiopulmonary Rehabilitation and Prevention
|
January 24, 2020
High Submaximal Exercise Heart Rate Impacts Exercise Intolerance in the Postural Orthostatic Tachycardia Syndrome
Erik H Van Iterson, Luke J Laffin, Kenneth A Mayuga, et al.
JAMA Cardiology
|
May 27, 2026
Bempedoic Acid and Venous Thromboembolism Risk Among Statin-Intolerant Patients: A Post Hoc Analysis of the CLEAR Outcomes Randomized Clinical Trial
Bernardo F Spiazzi, Danielle Brennan, Carolina P Zingano, et al.
Circulation
|
December 6, 2021
Rise in Blood Pressure Observed Among US Adults During the COVID-19 Pandemic
Luke J Laffin, Harvey W Kaufman, Zhen Chen, et al.
JAMA
|
September 10, 2023
Aldosterone Synthase Inhibition With Lorundrostat for Uncontrolled Hypertension: The Target-HTN Randomized Clinical Trial
Luke J Laffin, David Rodman, James M Luther, et al.
The International Journal of Cardiovascular Imaging
|
February 17, 2018
Focused cardiac ultrasound as a predictor of readmission in acute decompensated heart failure
Luke J Laffin, Amit V Patel, Narayan Saha, et al.
Hemodialysis International. International Symposium on Home Hemodialysis
|
March 30, 2019
Amylose resistant starch (HAM-RS2) supplementation increases the proportion of Faecalibacterium bacteria in end-stage renal disease patients: Microbial analysis from a randomized placebo-controlled trial
Michael R Laffin, Hamid Tayebi Khosroshahi, Heekuk Park, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 85) with videos related to
Sort By:
Page
of 9
Cleveland Clinic Journal of Medicine
|
September 2, 2025
Optimizing hypertension treatment: Evidence-based approaches and new drugs
Astefanos Al-Dalakta, Ahmad Ghanem, Chadi Tabaja, et al.
American Journal of Preventive Cardiology
|
July 6, 2026
The impact of bempedoic acid on cardiovascular events across the spectrum of kidney function, a CLEAR Outcomes trial secondary analysis
Carolina P Zingano, Danielle Brennan, LeAnne Bloedon, et al.
Current Cardiology Reports
|
August 14, 2024
Blood Pressure Time in Target Range and its Impact on Clinical Outcomes
Astefanos Al-Dalakta, Chadi Tabaja, Issam Motairek, et al.
Clinical Kidney Journal
|
August 5, 2025
From pathophysiology to novel approaches for obesity-associated hypertension
Mehmet Kanbay, Elif Yayci, Candan Genc, et al.
Journal of Cardiopulmonary Rehabilitation and Prevention
|
January 24, 2020
High Submaximal Exercise Heart Rate Impacts Exercise Intolerance in the Postural Orthostatic Tachycardia Syndrome
Erik H Van Iterson, Luke J Laffin, Kenneth A Mayuga, et al.
JAMA Cardiology
|
May 27, 2026
Bempedoic Acid and Venous Thromboembolism Risk Among Statin-Intolerant Patients: A Post Hoc Analysis of the CLEAR Outcomes Randomized Clinical Trial
Bernardo F Spiazzi, Danielle Brennan, Carolina P Zingano, et al.
Circulation
|
December 6, 2021
Rise in Blood Pressure Observed Among US Adults During the COVID-19 Pandemic
Luke J Laffin, Harvey W Kaufman, Zhen Chen, et al.
JAMA
|
September 10, 2023
Aldosterone Synthase Inhibition With Lorundrostat for Uncontrolled Hypertension: The Target-HTN Randomized Clinical Trial
Luke J Laffin, David Rodman, James M Luther, et al.
The International Journal of Cardiovascular Imaging
|
February 17, 2018
Focused cardiac ultrasound as a predictor of readmission in acute decompensated heart failure
Luke J Laffin, Amit V Patel, Narayan Saha, et al.
Hemodialysis International. International Symposium on Home Hemodialysis
|
March 30, 2019
Amylose resistant starch (HAM-RS2) supplementation increases the proportion of Faecalibacterium bacteria in end-stage renal disease patients: Microbial analysis from a randomized placebo-controlled trial
Michael R Laffin, Hamid Tayebi Khosroshahi, Heekuk Park, et al.
Page
of 9